GLOBEIMMUNE INC COM STK (DE)
GBIM
GBIM was delisted on the 22nd of July, 2016.
1 hedge funds and large institutions have $822K invested in GLOBEIMMUNE INC COM STK (DE) in 2016 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 10 closing their positions.
41% less capital invested
Capital invested by funds: $1.4M → $822K (-$577K)
91% less funds holding
Funds holding: 11 → 1 (-10)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 10
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$47K |
| 2 |
YP
Yellowstone Partners
Idaho Falls,
Idaho
|
-$32K |
| 3 |
TSS
Two Sigma Securities
New York
|
-$31K |
| 4 |
AIM
Acrospire Investment Management
Chicago,
Illinois
|
-$7K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$2K |
GBIM Hedge Fund Activity: Q3 2016 in Review
1 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in GLOBEIMMUNE INC COM STK (DE) (GBIM) for Q3 2016, worth a combined $822K — down 41% from $1.4M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of GBIM and 0 opened new positions — a net loss of 10 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Vanguard Group, exiting entirely with an estimated $47K sold.
- 1 institutional investor held GLOBEIMMUNE INC COM STK (DE) (GBIM) as of Q3 2016, down from 11 in Q2 2016.
- Funds reported $822K of GLOBEIMMUNE INC COM STK (DE) stock for Q3 2016, down 41% quarter-over-quarter.
- 0 funds opened new GLOBEIMMUNE INC COM STK (DE) positions in Q3 2016 and 10 closed out, a net change of -10 holders.
- The largest GLOBEIMMUNE INC COM STK (DE) seller in Q3 2016 was Vanguard Group, an estimated $47K sold.
Based on aggregated 13F filings for Q3 2016.